People have written a lot about Martin Shkreli. Now he’ll reflect on the week during a panel with some of biopharma’s best journalists at 4 pm Eastern today – and it will be broadcast live online.
Shkreli will join MedCity News biotech-pharma reporter Meghana Keshavan, John Carroll from FierceBiotech and Luke Timmerman from the Timmerman Report on MedHeads, MedCityNews.com’s weekly broadcast looking at the week’s most important issues on innovation in the business of healthcare.
We’ll first tackle the uproar around the price increase of Daraprim, the ripple effects of the debate, and the bigger issue of up-pricing drugs.
If there’s time, we’ll also discuss the revelations of precision medicine, including Human Longevity CEO J. Craig Venter’s announcement of low-cost exome testing and his feelings on genomics in the public domain.
MedHeads starts at 4 p.m. EDT on Friday, as it does every week. Join us via the YouTube embed below, or on our Google Hangout On Air page.
